Physicians Struggle to Help Diabetes Patients Get Tirzepatide
Endocrinologists say patients are once again having trouble accessing injectable medications they use to control type 2 diabetes, this time with tirzepatide (Mounjaro). Thanks to record demand, supply chain issues, and what some experts say is inappropriate off-label prescribing, endocrinologists said there has been a shortage in recent weeks which has pharmacies backed up and […]